Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Cell Rep ; 42(9): 113066, 2023 09 26.
Article in English | MEDLINE | ID: mdl-37656620

ABSTRACT

Fear-related disorders arise from inefficient fear extinction and have immeasurable social and economic costs. Here, we characterize mouse phenotypes that spontaneously show fear-independent behavioral traits predicting adaptive or maladaptive fear extinction. We find that, already before fear conditioning, specific morphological, electrophysiological, and transcriptomic patterns of cortical and amygdala pyramidal neurons predispose to fear-related disorders. Finally, by using an optogenetic approach, we show the possibility to rescue inefficient fear extinction by activating infralimbic pyramidal neurons and to impair fear extinction by activating prelimbic pyramidal neurons.


Subject(s)
Fear , Prefrontal Cortex , Mice , Animals , Prefrontal Cortex/physiology , Fear/physiology , Transcriptome/genetics , Extinction, Psychological/physiology , Amygdala/physiology , Pyramidal Cells/physiology
2.
Cell Death Dis ; 13(4): 381, 2022 04 20.
Article in English | MEDLINE | ID: mdl-35444186

ABSTRACT

The pathogenic mechanisms that underlie the progression of remote degeneration after spinal cord injury (SCI) are not fully understood. In this study, we examined the relationship between endoplasmic reticulum (ER) stress and macroautophagy, hereafter autophagy, and its contribution to the secondary damage and outcomes that are associated with remote degeneration after SCI. Using a rat model of spinal cord hemisection at the cervical level, we measured ER stress and autophagy markers in the axotomized neurons of the red nucleus (RN). In SCI animals, mRNA and protein levels of markers of ER stress, such as GRP78, CHOP, and GADD34, increased 1 day after the injury, peaking on Day 5. Notably, in SCI animals, the increase of ER stress markers correlated with a blockade in autophagic flux, as evidenced by the increase in microtubule-associated protein 2 light chain 3 (LC3-II) and p62/SQSTM1 (p62) and the decline in LAMP1 and LAMP2 levels. After injury, treatment with guanabenz protected neurons from UPR failure and increased lysosomes biogenesis, unblocking autophagic flux. These effects correlated with greater activation of TFEB and improved neuronal survival and functional recovery-effects that persisted after suspension of the treatment. Collectively, our results demonstrate that in remote secondary damage, impairments in autophagic flux are intertwined with ER stress, an association that contributes to the apoptotic cell death and functional damage that are observed after SCI.


Subject(s)
Autophagosomes , Spinal Cord Injuries , Animals , Apoptosis , Autophagosomes/metabolism , Autophagy , Endoplasmic Reticulum Stress , Proteostasis , Rats , Spinal Cord/pathology , Spinal Cord Injuries/pathology
3.
Brain Behav Immun ; 94: 89-103, 2021 05.
Article in English | MEDLINE | ID: mdl-33677027

ABSTRACT

Trauma to the central nervous system (CNS) is a devastating condition resulting in severe functional impairments that strongly vary among patients. Patients' features, such as age, social and cultural environment, and pre-existing psychiatric conditions may be particularly relevant for determining prognosis after CNS trauma. Although several studies demonstrated the impact of adult psycho-social stress exposure on functional recovery after CNS damage, no data exist regarding the long-term effects of the exposure to such experience at an early age. Here, we assessed whether early life stress (ELS) hampers the neuroinflammatory milieuand the functional recovery after focal brain injury in adulthood by using a murine model of ELS exposure combined with hemicerebellectomy (HCb), a model of remote damage. We found that ELS permanently altered microglia responses such that, once experienced HCb, they produced an exaggerated remote inflammatory response - consistent with a primed phenotype - associated with increased cell death and worse functional recovery. Notably, prevention of microglia/macrophages activation by GW2580 treatment during ELS exposure significantly reduced microglia responses, cell death and improved functional recovery. Conversely, GW2580 treatment administered in adulthood after HCb was ineffective in reducing inflammation and cell death or improving functional recovery. Our findings highlight that ELS impacts the immune system maturation producing permanent changes, and that it is a relevant factor modulating the response to a CNS damage. Further studies are needed to clarify the mechanisms underlying the interaction between ELS and brain injury with the aim of developing targeted treatments to improve functional recovery after CNS damage.


Subject(s)
Adverse Childhood Experiences , Brain Injuries , Adult , Animals , Cell Death , Humans , Mice , Microglia , Recovery of Function
4.
Semin Cell Dev Biol ; 94: 104-111, 2019 10.
Article in English | MEDLINE | ID: mdl-30703556

ABSTRACT

The CNS is endowed with an intrinsic ability to recover from and adapt secondary compensatory mechanisms to injury. The basis of recovery stems from brain plasticity, defined as the brain's ability to make adaptive changes on structural and functional levels, ranging from molecular, synaptic, and cellular changes in response to alterations in their environment. In this multitude of responses, microglia have an active role and contribute to brain plasticity through their dynamic responses. This review will provide an overview of microglial responses in the context of acute CNS injury and their function in post-traumatic repair and assess the changes that are induced by damage in remote areas from, but functionally connected to, the primary site of injury. In the second section, we highlight the effects of several therapeutic approaches, with particular interest paid to specialized pro-resolving lipid mediators, in modulating microglial responses in remote regions and enhancing long-term functional recovery via suppression of neurodegenerative cascades that are induced by damage, which may contribute to a translational bridge from bench to bedside.


Subject(s)
Brain Injuries/metabolism , Cell Plasticity , Microglia/metabolism , Animals , Brain Injuries/pathology , Humans , Microglia/pathology
5.
Mol Neurobiol ; 55(8): 6894-6905, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29357041

ABSTRACT

Remote damage is a secondary phenomenon that usually occurs after a primary brain damage in regions that are distant, yet functionally connected, and that is critical for determining the outcomes of several CNS pathologies, including traumatic brain and spinal cord injuries. The understanding of remote damage-associated mechanisms has been mostly achieved in several models of focal brain injury such as the hemicerebellectomy (HCb) experimental paradigm, which helped to identify the involvement of many key players, such as inflammation, oxidative stress, apoptosis and autophagy. Currently, few interventions have been shown to successfully limit the progression of secondary damage events and there is still an unmet need for new therapeutic options. Given the emergence of the novel concept of resolution of inflammation, mediated by the newly identified ω3-derived specialized pro-resolving lipid mediators, such as resolvins, we reported a reduced ability of HCb-injured animals to produce resolvin D1 (RvD1) and an increased expression of its target receptor ALX/FPR2 in remote brain regions. The in vivo administration of RvD1 promoted functional recovery and neuroprotection by reducing the activation of Iba-1+ microglia and GFAP+ astrocytes as well as by impairing inflammatory-induced neuronal cell death in remote regions. These effects were counteracted by intracerebroventricular neutralization of ALX/FPR2, whose activation by RvD1 also down-regulated miR-146b- and miR-219a-1-dependent inflammatory markers. In conclusion, we propose that innovative therapies based on RvD1-ALX/FPR2 axis could be exploited to curtail remote damage and enable neuroprotective effects after acute focal brain damage.


Subject(s)
Brain Injuries/drug therapy , Brain Injuries/physiopathology , Brain/pathology , Docosahexaenoic Acids/therapeutic use , Inflammation/drug therapy , MicroRNAs/metabolism , Receptors, Lipoxin/metabolism , Recovery of Function , Animals , Brain Injuries/pathology , Cell Death/drug effects , Cerebellum/surgery , Docosahexaenoic Acids/chemistry , Docosahexaenoic Acids/pharmacology , Down-Regulation/drug effects , Inflammation/pathology , Male , MicroRNAs/genetics , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuroprotection/drug effects , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Rats, Wistar
6.
Addict Biol ; 22(4): 911-922, 2017 Jul.
Article in English | MEDLINE | ID: mdl-26870906

ABSTRACT

Childhood maltreatment is associated with increased severity of substance use disorder and frequent relapse to drug use following abstinence. However, the molecular and neurobiological substrates that are engaged during early traumatic events and mediate the greater risk of relapse are poorly understood and knowledge of risk factors is to date extremely limited. In this study, we modeled childhood maltreatment by exposing juvenile mice to a threatening social experience (social stressed, S-S). We showed that S-S experience influenced the propensity to reinstate cocaine-seeking after periods of withdrawal in adulthood. By exploring global gene expression in blood leukocytes we found that this behavioral phenotype was associated with greater blood coagulation. In parallel, impairments in brain microvasculature were observed in S-S mice. Furthermore, treatment with an anticoagulant agent during withdrawal abolished the susceptibility to reinstate cocaine-seeking in S-S mice. These findings provide novel insights into a possible molecular mechanism by which childhood maltreatment heightens the risk for relapse in cocaine-dependent individuals.


Subject(s)
Blood Coagulation/physiology , Brain/blood supply , Cocaine-Related Disorders/etiology , Cocaine/administration & dosage , Social Behavior , Stress, Psychological/complications , Animals , Behavior, Animal , Cocaine-Related Disorders/physiopathology , Disease Models, Animal , Male , Mice , Mice, Inbred DBA , Stress, Psychological/physiopathology
7.
Mol Neurobiol ; 54(7): 4896-4907, 2017 09.
Article in English | MEDLINE | ID: mdl-27514755

ABSTRACT

Spinal cord injuries (SCIs) are devastating conditions of the central nervous system (CNS) for which there are no restorative therapies. Neuronal death at the primary lesion site and in remote regions that are functionally connected to it is one of the major contributors to neurological deficits following SCI.Disruption of autophagic flux induces neuronal death in many CNS injuries, but its mechanism and relationship with remote cell death after SCI are unknown. We examined the function and effects of the modulation of autophagy on the fate of axotomized rubrospinal neurons in a rat model of spinal cord dorsal hemisection (SCH) at the cervical level. Following SCH, we observed an accumulation of LC3-positive autophagosomes (APs) in the axotomized neurons 1 and 5 days after injury. Furthermore, this accumulation was not attributed to greater initiation of autophagy but was caused by a decrease in AP clearance, as demonstrated by the build-up of p62, a widely used marker of the induction of autophagy. In axotomized rubrospinal neurons, the disruption of autophagic flux correlated strongly with remote neuronal death and worse functional recovery. Inhibition of AP biogenesis by 3-methyladenine (3-MA) significantly attenuated remote degeneration and improved spontaneous functional recovery, consistent with the detrimental effects of autophagy in remote damage after SCH. Collectively, our results demonstrate that autophagic flux is blocked in axotomized neurons on SCI and that the inhibition of AP formation improves their survival. Thus, autophagy is a promising target for the development of therapeutic interventions in the treatment of SCIs.


Subject(s)
Autophagy , Neurons , Spinal Cord Injuries/pathology , Adenine/analogs & derivatives , Adenine/pharmacology , Animals , Autophagy/drug effects , Disease Models, Animal , Lysosomes/drug effects , Lysosomes/metabolism , Male , Microtubule-Associated Proteins/metabolism , Neurons/drug effects , Neurons/metabolism , Rats, Wistar , Recovery of Function/drug effects , Spinal Cord/drug effects , Spinal Cord/pathology , Spinal Cord Injuries/drug therapy
8.
J Neuroinflammation ; 13(1): 150, 2016 06 14.
Article in English | MEDLINE | ID: mdl-27301743

ABSTRACT

BACKGROUND: After focal brain injuries occur, in addition to the effects that are attributable to the primary site of damage, the resulting functional impairments depend highly on changes that occur in regions that are remote but functionally connected to the site of injury. Such effects are associated with apoptotic and inflammatory cascades and are considered to be important predictors of outcome. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique that is used to treat various central nervous system (CNS) pathologies and enhance functional recovery after brain damage. OBJECTIVE: This study examined the efficacy of rTMS in mitigating remote degeneration and inflammation and in improving functional recovery in a model of focal brain damage. METHODS: Rats that were undergoing hemicerebellectomy (HCb) were treated with an rTMS protocol for 7 days, and neuronal death indices, glial activation, and functional recovery were assessed. RESULTS: rTMS significantly reduced neuronal death and glial activation in remote regions and improved functional recovery. CONCLUSIONS: Our finding opens up a completely new scenario for exploiting the potential of rTMS as an anti-apoptotic and anti-inflammatory treatment.


Subject(s)
Apoptosis/radiation effects , Brain Injuries/complications , Inflammation/etiology , Inflammation/therapy , Transcranial Magnetic Stimulation , Animals , Brain Injuries/pathology , Calcium-Binding Proteins/metabolism , Cytochromes c/metabolism , Disease Models, Animal , Gene Expression Regulation/radiation effects , Glial Fibrillary Acidic Protein/metabolism , Male , Microfilament Proteins/metabolism , Neuroglia/metabolism , Phosphopyruvate Hydratase/metabolism , RNA, Messenger , Rats , Rats, Wistar , Recovery of Function/radiation effects
9.
Neuropharmacology ; 107: 305-316, 2016 08.
Article in English | MEDLINE | ID: mdl-27026110

ABSTRACT

Stress-related psychiatric disorders, including anxiety, are complex diseases that have genetic, and environmental causes. Stressful experiences increase the release of prefrontal amygdala neurotransmitters, a response that is relevant to cognitive, emotional, and behavioral coping. Moreover, exposure to stress elicits anxiety-like behavior and dendritic remodeling in the amygdala. Members of the miR-34 family have been suggested to regulate synaptic plasticity and neurotransmission processes, which mediate stress-related disorders. Using mice that harbored targeted deletions of all 3 members of the miR-34-family (miR-34-TKO), we evaluated acute stress-induced basolateral amygdala (BLA)-GABAergic and medial prefrontal cortex (mpFC) aminergic outflow by intracerebral in vivo microdialysis. Moreover, we also examined fear conditioning/extinction, stress-induced anxiety, and dendritic remodeling in the BLA of stress-exposed TKO mice. We found that TKO mice showed resilience to stress-induced anxiety and facilitation in fear extinction. Accordingly, no significant increase was evident in aminergic prefrontal or amygdala GABA release, and no significant acute stress-induced amygdalar dendritic remodeling was observed in TKO mice. Differential GRM7, 5-HT2C, and CRFR1 mRNA expression was noted in the mpFC and BLA between TKO and WT mice. Our data demonstrate that the miR-34 has a critical function in regulating the behavioral and neurochemical response to acute stress and in inducing stress-related amygdala neuroplasticity.


Subject(s)
Anxiety/metabolism , Gene Deletion , MicroRNAs/metabolism , Nerve Net/metabolism , Stress, Psychological/metabolism , Animals , Anxiety/genetics , Anxiety/psychology , Extinction, Psychological/physiology , Fear/physiology , Fear/psychology , Male , Mice , Mice, Knockout , MicroRNAs/genetics , Stress, Psychological/genetics , Stress, Psychological/psychology
10.
Front Behav Neurosci ; 9: 66, 2015.
Article in English | MEDLINE | ID: mdl-25814946

ABSTRACT

Environmental enrichment (EE) is a widely used paradigm for investigating the influence of complex stimulations on brain and behavior. Here we examined whether pre-reproductive exposure to EE of female rats may influence their maternal care and offspring cognitive performances. To this aim, from weaning to breeding age enriched females (EF) were reared in enriched environments. Females reared in standard conditions were used as controls. At 2.5 months of age all females were mated and reared in standard conditions with their offspring. Maternal care behaviors and nesting activity were assessed in lactating dams. Their male pups were also behaviorally evaluated at different post-natal days (pnd). Brain BDNF, reelin and adult hippocampal neurogenesis levels were measured as biochemical correlates of neuroplasticity. EF showed more complex maternal care than controls due to their higher levels of licking, crouching and nest building activities. Moreover, their offspring showed higher discriminative (maternal odor preference T-maze, pnd 10) and spatial (Morris Water Maze, pnd 45; Open Field with objects, pnd 55) performances, with no differences in social abilities (Sociability test, pnd 35), in comparison to controls. BDNF levels were increased in EF frontal cortex at pups' weaning and in their offspring hippocampus at pnd 21 and 55. No differences in offspring reelin and adult hippocampal neurogenesis levels were found. In conclusion, our study indicates that pre-reproductive maternal enrichment positively influences female rats' maternal care and cognitive development of their offspring, demonstrating thus a transgenerational transmission of EE benefits linked to enhanced BDNF-induced neuroplasticity.

11.
Cerebellum ; 14(1): 15-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25253422

ABSTRACT

When CNS lesions develop, neuronal degeneration occurs locally but in regions that are remote, yet functionally connected, to the primary lesion site. This process, known as "remote damage," significantly affects long-term outcomes in many CNS pathologies, such as stroke, multiple sclerosis, and traumatic brain and spinal cord injuries. Remote damage can last several days or months after the primary lesion, providing a window during which therapeutic approaches can be implemented to effect neuroprotection. The recognition of the importance of remote damage in determining disease outcomes has prompted considerable interest in examining remote damage-associated mechanisms, most of which is derived from the potential of this research to develop innovative pharmacological approaches for preserving neurons and improving functional outcomes. To this end, the hemicerebellectomy (HCb) experimental paradigm has been instrumental in highlighting the complexity and variety of the systems that are involved, identifying mechanisms of life/death decisions, and providing a testing ground for novel neuroprotective approaches. Inflammation, oxidative stress, apoptosis, autophagy, and neuronal changes in receptor mosaics are several remote damage mechanisms that have been identified and examined using the HCb model. In this review, we discuss our current understanding of remote degeneration mechanisms and their potential for exploitation with regard to neuroprotective approaches, focusing on HCb studies.


Subject(s)
Cerebellum/physiopathology , Nerve Degeneration/physiopathology , Animals , Cell Death/physiology , Cerebellum/pathology , Disease Models, Animal , Nerve Degeneration/pathology , Neurons/physiology
12.
Ann Neurol ; 73(5): 626-36, 2013 May.
Article in English | MEDLINE | ID: mdl-23447381

ABSTRACT

OBJECTIVE: The immunopathogenesis of multiple sclerosis (MS) has always been thought to be driven by chronically activated and autoreactive Th-1 and Th-17 cells. Recently, dendritic cells (DCs) have also been thought to significantly contribute to antigenic spread and to maturation of adaptive immunity, and have been linked with disease progression and exacerbation. However, the role of DCs in MS pathogenesis remains poorly understood. METHODS: We compared the level of cytokine production by myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) in healthy subjects and MS patients, following in vitro stimulation of Toll-like receptors 7/8. We also evaluated the effect of the main endocannabinoid, anandamide (AEA), in these DC subsets and correlated cytokine levels with defects in the endocannabinoid system. RESULTS: mDCs obtained from MS patients produce higher levels of interleukin-12 and interleukin-6, whereas pDCs account for lower levels of interferon-α compared to healthy subjects. AEA significantly inhibited cytokine production from healthy mDCs and pDCs, as well as their ability to induce Th-1 and Th-17 lineages. Moreover, we found that in MS only pDCs lack responsiveness to cytokine inhibition induced by AEA. Consistently, this specific cell subset expresses higher levels of the anandamide hydrolase fatty acid amide hydrolase (FAAH). INTERPRETATION: Our data disclose a distinct immunomodulatory effect of AEA in mDCs and pDCs from MS patients, which may reflect an alteration of the expression of FAAH, thus forming the basis for the rational design of new endocannabinoid-based immunotherapeutic agents targeting a specific cell subset.


Subject(s)
Arachidonic Acids , Cannabinoid Receptor Agonists , Dendritic Cells/immunology , Endocannabinoids , Multiple Sclerosis/pathology , Myeloid Cells/immunology , Polyunsaturated Alkamides , Adolescent , Adult , Aged , Amidohydrolases/genetics , Amidohydrolases/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Cytokines/genetics , Cytokines/metabolism , Dendritic Cells/drug effects , Female , Gene Expression Regulation/drug effects , Gene Expression Regulation/immunology , Humans , Male , Middle Aged , Myeloid Cells/drug effects , RNA, Messenger/metabolism , Receptor, Cannabinoid, CB2/genetics , Receptor, Cannabinoid, CB2/metabolism , Toll-Like Receptor 7/genetics , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 8/genetics , Toll-Like Receptor 8/metabolism , Young Adult
13.
Cell Mol Life Sci ; 70(12): 2191-204, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23296125

ABSTRACT

Endocannabinoids (eCBs) and glucocorticoids (GCs) are two distinct classes of signaling lipids that exert both neuroprotective and immunosuppressive effects; however, the possibility of an actual interaction of their receptors [i.e., type-2 cannabinoid (CB2) and glucocorticoid receptor α (GRα), respectively] remains unexplored. Here, we demonstrate that the concomitant activation of CB2 and GRα abolishes the neuroprotective effects induced by each receptor on central neurons and on glial cells in animal models of remote cell death. We also show that the ability of eCBs and GCs, used individually, to inhibit tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) production from activated human T lymphocytes is lost when CB2 and GRα are activated simultaneously. In addition, signal transduction pathways triggered by concomitant activation of both receptors led to increased levels of GRß, heat-shock proteins-70 and -90, and p-JNK, as well as to reduced levels of p-STAT6. These effects were reversed only by selectively antagonizing CB2, but not GRα. Overall, our study demonstrates for the first time the existence of a CB2-driven negative cross-talk between eCB and GC signaling in both rats and humans, thus paving the way to the possible therapeutic exploitation of CB2 as a new target for chronic inflammatory and neurodegenerative diseases.


Subject(s)
Neuroglia/metabolism , Neurons/metabolism , Receptor Cross-Talk/physiology , Receptor, Cannabinoid, CB2/metabolism , Receptors, Glucocorticoid/metabolism , Signal Transduction/physiology , Analysis of Variance , Animals , Blotting, Western , Endocannabinoids/metabolism , Flow Cytometry , Glucocorticoids/metabolism , Humans , Immunohistochemistry , Immunoprecipitation , Interferon-gamma/metabolism , Male , Rats , Rats, Wistar , T-Lymphocytes/metabolism , Tumor Necrosis Factor-alpha/metabolism
14.
Mol Reprod Dev ; 79(12): 853-60, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23071005

ABSTRACT

Sperm-mediated gene transfer (SMGT), the ability of sperm cells to spontaneously incorporate exogenous DNA and to deliver it to oocytes during fertilization, has been proposed as an easy and efficient method for producing transgenic animals. SMGT is still undergoing development and optimization to improve the uptake efficiency of foreign DNA by sperm cells, which is a preliminary, yet critical, step for successful SMGT. Towards this aim, we developed a quantitative, real-time PCR-based assay to assess the absolute number of exogenous plasmids internalized into the spermatozoon. Using this technique, we found that the circular form of the DNA is more efficiently taken up than the linearized form. We also found that DNA internalization into the nucleus of porcine sperm cells is better under specific methyl-ß-cyclodextrin (MCD)-treated conditions, where the plasma membrane properties were altered without significantly compromising sperm physiology. These results provide the first evidence that membrane cholesterol depletion by MCD might represent a novel strategy for enhancing the ability of sperm to take up heterologous DNA.


Subject(s)
Cholesterol/metabolism , DNA, Circular/metabolism , Plasmids/genetics , Plasmids/metabolism , beta-Cyclodextrins/pharmacology , Animals , Biological Transport , DNA/metabolism , Fertilization/genetics , Gene Transfer Techniques , Male , Polymerase Chain Reaction , Spermatozoa/cytology , Spermatozoa/metabolism , Sus scrofa
15.
Autophagy ; 8(2): 222-35, 2012 Feb 01.
Article in English | MEDLINE | ID: mdl-22248716

ABSTRACT

Autophagy is the evolutionarily conserved degradation and recycling of cellular constituents. In mammals, autophagy is implicated in the pathogenesis of many neurodegenerative diseases. However, its involvement in acute brain damage is unknown. This study addresses the function of autophagy in neurodegeneration that has been induced by acute focal cerebellar lesions. We provide morphological, ultrastructural, and biochemical evidence that lesions in a cerebellar hemisphere activate autophagy in axotomized precerebellar neurons. Through time course analyses of the apoptotic cascade, we determined mitochondrial dysfunction to be the early trigger of degeneration. Further, the stimulation of autophagy by rapamycin and the employment of mice with impaired autophagic responses allowed us to demonstrate that autophagy protects from damage promoting functional recovery. These findings have therapeutic significance, demonstrating the potential of pro-autophagy treatments for acute brain pathologies, such as stroke and brain trauma.


Subject(s)
Autophagy/drug effects , Brain Injuries/complications , Cytoprotection/drug effects , Nerve Degeneration/prevention & control , Neurons/drug effects , Neuroprotective Agents/pharmacology , Sirolimus/pharmacology , Animals , Apoptosis Regulatory Proteins/metabolism , Axotomy , Beclin-1 , Brain Injuries/drug therapy , Brain Injuries/pathology , Cerebellum/drug effects , Cerebellum/surgery , Chloroquine/pharmacology , Cytochromes c/metabolism , Mice , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/pathology , Mitochondria/ultrastructure , Nerve Degeneration/drug therapy , Nerve Degeneration/etiology , Nerve Degeneration/pathology , Neurons/cytology , Neurons/pathology , Neurons/ultrastructure , Neuroprotective Agents/therapeutic use , Phagosomes/drug effects , Phagosomes/metabolism , Phagosomes/ultrastructure , Sirolimus/therapeutic use
16.
Eur J Neurosci ; 33(9): 1622-36, 2011 May.
Article in English | MEDLINE | ID: mdl-21453288

ABSTRACT

Organotypic cultures (OCs) have been widely used to investigate the midbrain dopaminergic system, but only a few studies focused on the functional properties of dopaminergic neurons and their synaptic inputs from dopaminergic and non-dopaminergic neurons also contained in such cultures. In addition, it is not clear whether the culturing process affects the intrinsic neuronal properties and the expression of specific receptors and transporters. We performed patch-clamp recordings from dopaminergic neurons in mesencephalic-striatal co-cultures obtained from transgenic mice expressing green fluorescent protein (GFP) under the tyrosine hydroxylase promoter. Some (10/44) GFP+ neurons displayed a bursting activity that renders the firing of these cells similar to that of the dopaminergic neurons in vivo. The culturing process reduced the hyperpolarization-activated current (I(h) ) and the expression of D2 receptors. Downregulation of D2 receptor mRNA and protein was confirmed with reverse transcriptase polymerase chain reaction and Western blotting. Immunocytochemistry revealed that many synaptic terminals, most likely originating from dopaminergic neurons, co-expressed the dopamine (DA) transporter and the vesicular glutamate transporter-2, suggesting a co-release of DA and glutamate. Interestingly, exogenous DA decreased glutamate release in young cultures [days in vitro (DIV)<20] by acting on pre-synaptic D2 receptors, while in older cultures (DIV>26) DA increased glutamate release by acting on α-1 adrenoreceptors. The facilitatory effect of DA on glutamatergic transmission to midbrain dopaminergic neurons may be important in conditions when the expression of D2 receptors is compromised, such as long-term treatment with antipsychotic drugs. Our data show that midbrain OCs at DIV>26 may provide a suitable model of such conditions.


Subject(s)
Corpus Striatum/cytology , Dopamine/metabolism , Glutamic Acid/metabolism , Mesencephalon/cytology , Neurons/cytology , Neurons/metabolism , Receptors, Adrenergic, alpha-1/metabolism , Action Potentials/physiology , Animals , Cells, Cultured , Coculture Techniques , Dopamine Plasma Membrane Transport Proteins/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Mice , Mice, Transgenic , Patch-Clamp Techniques , Receptors, GABA-A/metabolism , Sodium Channel Blockers/metabolism , Synapses/physiology , Synaptic Transmission/physiology , Tetrodotoxin/metabolism , Vesicular Glutamate Transport Protein 2/genetics , Vesicular Glutamate Transport Protein 2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...